---
schema_version: "secwatch.filing_event.v1"
accession: "0001503274-24-000006"
form_type: "8-K"
ticker: "QTRX"
cik: "0001503274"
company_name: "Quanterix Corp"
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:52:00.902668+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Quanterix Q2 revenue up 11% to $34.4M; net loss widens to $9.5M; cuts FY2024 revenue guidance

## Summary
- Revenue $34.4M (+10.8% YoY); GAAP gross margin 58.3% vs 61.7% prior year.
- Net loss $9.5M, up $3.4M from prior year; cash usage $5.1M in quarter.
- Revised FY2024 revenue guidance to $134M-$138M from $139M-$144M due to constrained capital environment.
- Cash usage for 2024 now expected at higher end of $25M-$30M range.
- New Alzheimer's diagnostic partnerships with Mt. Sinai, Banner Health, UCSF, and KingMed Diagnostics.

## SEC filing metadata
- accession: 0001503274-24-000006
- form_type: 8-K
- ticker: QTRX
- cik: 0001503274
- company_name: Quanterix Corp
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1503274/000150327424000006/0001503274-24-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1503274/000150327424000006/qtrx-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001503274-24-000006
- JSON: https://secwatch.observer/filing/0001503274-24-000006.json
- Plain text: https://secwatch.observer/filing/0001503274-24-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.